Healthcare Models for Postpartum Hypertension
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Community Health Model (CHM), Remote Medical Model (RMM), Telehealth Model, Virtual Care Model, SoC, Standard of Care for Postpartum Hypertension?
The patient-centered medical home (PCMH) model, which shares similarities with the Community Health Model and other care models, has shown potential in improving care for patients with chronic conditions by providing coordinated, comprehensive, and accessible services. This approach may indirectly support the effectiveness of these models in managing postpartum hypertension by enhancing care delivery and patient outcomes.12345
Is the healthcare model for postpartum hypertension safe for humans?
How is the Community Health Model (CHM) and Remote Medical Model (RMM) treatment for postpartum hypertension unique?
The Community Health Model (CHM) and Remote Medical Model (RMM) for postpartum hypertension are unique because they emphasize patient-centered and team-based care, focusing on quality and safety, which is a shift from traditional hypertension treatments that may not prioritize these aspects. These models incorporate interprofessional collaboration and remote care, offering a more accessible and coordinated approach to managing high blood pressure after childbirth.29101112
What is the purpose of this trial?
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.
Research Team
Rafael Pérez-Escamilla, PhD
Principal Investigator
Yale University
Eligibility Criteria
This trial is for postpartum women who had a single live birth, speak English or Spanish, are on Medicaid or uninsured, and live in Connecticut, Massachusetts, or New York. They must be able to consent and not have severe medical conditions that interfere with participation. Women planning to move out of state soon or using illicit drugs cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Standard of Care
Participants receive standard postpartum care and are provided with an Omron blood pressure cuff
Remote Medical Model (RMM)
Participants receive remote monitoring with additional follow-up visits as needed for high blood pressure or mental health concerns
Community Health Model (CHM)
Incorporates community health workers/doulas providing postpartum hypertension support and mental health engagement
Follow-up
Participants are monitored for safety and effectiveness after treatment, including blood pressure checks and mental health assessments
Treatment Details
Interventions
- Community Health Model (CHM)
- Remote Medical Model (RMM)
- SoC
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator